Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19

Clinical trial NCT04473170 · COMPLETED

Trial details

NCT number: NCT04473170
Sponsor: Abu Dhabi Stem Cells Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Coronavirus Disease 2019 (COVID-19)

Start date: 2020-04-04
Primary completion: 2020-05-20
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.